-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Harpoon Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
- Harpoon Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $26.6 M, a 3107% increase year-over-year.
- Harpoon Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6.37 M, a 94.3% decline from 2021.
- Harpoon Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $112 M, a 2285% increase from 2020.
- Harpoon Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $4.68 M, a 93.5% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)